Correction: Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer

• E. C. de Heer,
• C. E. Zois,
• E. Bridges,
• B. van der Vegt,
• H. Sheldon,
• W. A. Veldman,
• M. C. Zwager,
• T. van der Sluis,
• S. Haider,
• T. Morita,
• O. Baba,
• C. P. Schröder,
• S. de Jong,
• A. L. Harris,
• M. Jalving

Affiliations

E. C. de Heer

Department of Medical Oncology, University of Groningen, University Medical Center Groningen

C. E. Zois

Department of Oncology, Weatherall Institute of Molecular Medicine, Hypoxia and Angiogenesis Group, Cancer Research UK Molecular Oncology Laboratories, University of Oxford

E. Bridges

Department of Oncology, Weatherall Institute of Molecular Medicine, Hypoxia and Angiogenesis Group, Cancer Research UK Molecular Oncology Laboratories, University of Oxford

B. van der Vegt

Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen

H. Sheldon

Department of Oncology, Weatherall Institute of Molecular Medicine, Hypoxia and Angiogenesis Group, Cancer Research UK Molecular Oncology Laboratories, University of Oxford

W. A. Veldman

Department of Medical Oncology, University of Groningen, University Medical Center Groningen

M. C. Zwager

Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen

T. van der Sluis

Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen

S. Haider

The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research

T. Morita

Tokushima University Graduate School

O. Baba

Tokushima University Graduate School

C. P. Schröder

Department of Medical Oncology, University of Groningen, University Medical Center Groningen

S. de Jong

Department of Medical Oncology, University of Groningen, University Medical Center Groningen

A. L. Harris

Department of Oncology, Weatherall Institute of Molecular Medicine, Hypoxia and Angiogenesis Group, Cancer Research UK Molecular Oncology Laboratories, University of Oxford

M. Jalving

Department of Medical Oncology, University of Groningen, University Medical Center Groningen